Literature DB >> 3131485

Developmental changes in ganglioside composition and synthesis in embryonic rat brain.

R K Yu1, L J Macala, T Taki, H M Weinfield, F S Yu.   

Abstract

Developmental changes in ganglioside composition and biosynthesis was studied in rat brain between embryonic day (E) 14 and birth. In E14 brains, GM3 and GD3 were predominant. At E16, "b" series gangliosides, such as GD1b, GT1b, and GQ1b, increased in content. After E18, "a" series gangliosides such as GM1, GD1a, and GT1a increased in content, and the content of GM3 and GD3 markedly decreased. Because of these changes in composition, we determined the activities, in homogenates of embryonic brains, of two key enzymes of ganglioside synthesis: sialyltransferase for the synthesis of GD3 from GM3 and N-acetylgalactosaminyltransferase for GM2 synthesis from GM3. The sialyltransferase activity (GM3----GD3) was constant between E14 and E18 but decreased rapidly from E18 to birth. In contrast, the N-acetylgalactosaminyltransferase activity (GM3----GM2) increased between E14 and E18 but was constant from E18 to birth. These changes in ganglioside composition and enzymatic activities indicate that during development there is a shift from synthesis of the simplest gangliosides of the "a" and "b" pathways to synthesis of the more complex gangliosides.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3131485     DOI: 10.1111/j.1471-4159.1988.tb02484.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  94 in total

1.  GM1 synthase depends on N-glycosylation for enzyme activity and trafficking to the Golgi complex.

Authors:  J A Martina; J L Daniotti; H J Maccioni
Journal:  Neurochem Res       Date:  2000-05       Impact factor: 3.996

Review 2.  Structures, biosynthesis, and functions of gangliosides--an overview.

Authors:  Robert K Yu; Yi-Tzang Tsai; Toshio Ariga; Makoto Yanagisawa
Journal:  J Oleo Sci       Date:  2011       Impact factor: 1.601

3.  Identification of an endogenous inhibitor of the UDP-N-acetylgalactosamine: GM3, N-acetylgalactosaminyl transferase as apolipoprotein A1.

Authors:  C B Conde; V R Grabois; S N Deza; B L Caputto
Journal:  Neurochem Res       Date:  1997-04       Impact factor: 3.996

4.  Glycosyltransferase activities in cultured endothelial cells of bovine brain microvascular origin.

Authors:  T Kanda; T Ariga; M Yamawaki; H Yoshino; X B Gu; R K Yu
Journal:  Neurochem Res       Date:  1997-04       Impact factor: 3.996

5.  Compartmental organization of the synthesis of GM3, GD3, and GM2 in golgi membranes from neural retina cells.

Authors:  M K Maxzúd; H J Maccioni
Journal:  Neurochem Res       Date:  1997-04       Impact factor: 3.996

6.  GD3 expression in CHO-K1 cells increases growth rate, induces morphological changes, and affects cell-substrate interactions.

Authors:  Jose L Daniotti; Adolfo R Zurita; Vera M T Trindade; Hugo J F Maccioni
Journal:  Neurochem Res       Date:  2002-11       Impact factor: 3.996

Review 7.  Neural stem cells redefined: a FACS perspective.

Authors:  Dragan Maric; Jeffery L Barker
Journal:  Mol Neurobiol       Date:  2004-08       Impact factor: 5.590

8.  GD2 expression is closely associated with neuronal differentiation of human umbilical cord blood-derived mesenchymal stem cells.

Authors:  Hye Jin Jin; Hae Yun Nam; Yun Kyong Bae; Soo Yeon Kim; I Rang Im; Wonil Oh; Yoon Sun Yang; Soo Jin Choi; Seong Who Kim
Journal:  Cell Mol Life Sci       Date:  2010-02-18       Impact factor: 9.261

Review 9.  The glycosphingolipid hydrolases in the central nervous system.

Authors:  Massimo Aureli; Maura Samarani; Nicoletta Loberto; Rosaria Bassi; Valentina Murdica; Simona Prioni; Alessandro Prinetti; Sandro Sonnino
Journal:  Mol Neurobiol       Date:  2013-11-27       Impact factor: 5.590

10.  Amyloid β-peptide 1-42 modulates the proliferation of mouse neural stem cells: upregulation of fucosyltransferase IX and notch signaling.

Authors:  Yutaka Itokazu; Robert K Yu
Journal:  Mol Neurobiol       Date:  2014-01-17       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.